InterCure Ltd.
INCR
$1.60
$0.053.23%
NASDAQ
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -- | -97.53% | 14.72% |
| Total Depreciation and Amortization | -- | -- | -- | -27.90% | 55.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | 116.25% | -206.44% |
| Change in Net Operating Assets | -- | -- | -- | -213.15% | 304.78% |
| Cash from Operations | -- | -- | -- | -220.21% | 722.63% |
| Capital Expenditure | -- | -- | -- | 85.49% | -9.92% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -235.88% | 122.37% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 85.90% | -244.51% |
| Cash from Investing | -- | -- | -- | 77.22% | -63.66% |
| Total Debt Issued | -- | -- | -- | -88.88% | 62.61% |
| Total Debt Repaid | -- | -- | -- | -41.01% | -218.91% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 16.30% | 61.03% |
| Cash from Financing | -- | -- | -- | -257.85% | 33.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | 109.05% | -129.31% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -- | -845.36% | 401.43% |